Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use

Journal of Alzheimer's Disease

Volumn 21, Issue 2, 2010, Pages 519-526

  Van Beek, Arenda H E A ^a   Sijbesma, Jaap C ^a   Jansen, Rene W M M ^b   Rikkert, Marcel G M Olde ^a   Claassen, Jurgen A H R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Location Alkmaar   (Netherlands)

Author keywords

Alzheimer's disease; cerebral blood flow; cholinesterase inhibitors; near infrared spectroscopy; transcranial Doppler ultrasonography

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GALANTAMINE; HEMOGLOBIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; ORTHOSTATIC HYPOTENSION; OXYGEN SUPPLY; PRIORITY JOURNAL;

EID: 77957336864     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100288     Document Type: Article

References (25)

1. Iadecola C, Park L, Capone C (2009) Threats to the mind: Aging, amyloid, and hypertension. Stroke 40, S40-S44.
2. Girouard H, Iadecola C (2006) Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 100, 328-335.
3. Claassen JA, DiazArrastia R, Martin-Cook K, Levine BD, Zhang R (2009) Altered cerebral hemodynamics in early Alzheimer disease: A pilot study using transcranial Doppler. J Alzheimers Dis 17, 621-629.
4. Han BH, Zhou ML, Abousaleh F, Brendza RP, Dietrich HH, KoenigsknechtTalboo J, Cirrito JR,Milner E, Holtzman DM, Zipfel GJ (2008) Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: Contribution of soluble and insoluble amyloidbeta peptide, partial restoration via gammasecretase inhibition. J Neurosci 28, 13542-13550.
5. Niwa K, Kazama K, Younkin L, Younkin SG, Carlson GA, Iadecola C (2002) Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 283, H315H323.
6. Claassen JA, JansenRW(2006)Cholinergicallymediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: The cholinergicvascular hypothesis. J Gerontol A Biol Sci Med Sci 61, 267-271.
7. Claassen JA, van Beek AH, Olde Rikkert MG (2009) Short review: Acetylcholinesteraseinhibitors in Alzheimer's disease have opposing effects on blood pressure and cerebral perfusion. J Nutr Health Aging 13, 231-233.
8. Van Beek AHEA, Claassen JAHR (2010) The cerebrovascular role of the cholinergic neural system in Alzheimer's disease. Behav Brain Res, in press.
9. BarKJ, BoettgerMK, SeidlerN,MentzelHJ, TerborgC, Sauer H (2007) Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy. Stroke 38, 3186-3192.
10. Rosengarten B, Paulsen S, Molnar S, Kaschel R, Gallhofer B, Kaps M (2006) Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients. J Neurol 253, 58-64.
11. van Beek AH, Claassen JA, Rikkert MG, Jansen RW (2008) Cerebral autoregulation: An overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab 28, 1071-1085.
12. Mehagnoul Schipper DJ, Vloet LC, Colier WN, Hoefnagels WH, Jansen RW (2000) Cerebral oxygenation declines in healthy elderly subjects in response to assuming the upright position. Stroke 31, 1615-1620.
13. Mehagnoul Schipper DJ, Colier WN, Jansen RW (2001) Reproducibility of orthostatic changes in cerebral oxygenation in healthy subjects aged 70 years or older. Clin Physiol 21, 77-84.
14. Giller CA, Bowman G, Dyer H, Mootz L, Krippner W(1993) Cerebral arterial diameters during changes in blood pressure and carbon dioxide during craniotomy. Neurosurgery 32, 737-741.
15. Newell DW, Aaslid R, Lam A, Mayberg TS,Winn HR (1994) Comparison of flow and velocity during dynamic autoregulation testing in humans. Stroke 25, 793-797. (Pubitemid 24111325)
16. Serrador JM, Picot PA, Rutt BK, Shoemaker JK, Bondar RL (2000) MRI measures of middle cerebral artery diameter in conscious humans during simulated orthostasis. Stroke 31, 1672-1678.
17. AaslidR,Markwalder TM,NornesH(1982)Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 57, 769-774.
18. den Heijer T., Launer LJ, Prins ND, van Dijk EJ, Vermeer SE, Hofman A, Koudstaal PJ, Breteler MM (2005) Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology 64, 263-267.
19. Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging andAlzheimer's disease. ProgNeurobiol 64, 575-611.
20. Yoshiura T, Hiwatashi A, Yamashita K, Ohyagi Y, Monji A, Takayama Y, Nagao E, Kamano H, Noguchi T, Honda H (2009) Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spinlabeling in patients with Alzheimer disease. AJNR Am J Neuroradiol 30, 1388-1393.
21. Teipel SJ, Drzezga A, Bartenstein P,Moller HJ, Schwaiger M, Hampel H (2006) Effects of donepezil on cortical metabolic response to activation during (18)FDGPET in Alzheimer's disease: A doubleblind crossover trial. Psychopharmacology (Berl) 187, 86-94.
22. Zhang R,Witkowski S, Fu Q, Claassen JA, Levine BD (2007) Cerebral hemodynamics after shortand longterm reduction in blood pressure in mild and moderate hypertension. Hypertension 49, 1149-1155.
23. Lipsitz LA,Mukai S,Hamner J,GagnonM, BabikianV(2000) Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension. Stroke 31, 1897-1903.
24. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J (1992) Atrophy of medial temporal lobes on MRI in probable Alzheimer's disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55, 967972.
25. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P; European Task Force on AgeRelated White Matter Changes (2001) A new rating scale for agerelated white matter changes applicable to MRI and CT. Stroke 32, 13181322.